Routine Gastroscopy and Colonoscopy Are NOT Recommended in Established Coeliac Disease
In established coeliac disease on a gluten-free diet, routine repeat gastroscopy is not necessary, and colonoscopy is only indicated for specific clinical scenarios—not as part of routine monitoring.
Gastroscopy/Upper Endoscopy with Duodenal Biopsy
Initial Diagnosis
- Gastroscopy with duodenal biopsy remains the reference standard for diagnosing coeliac disease initially 1
- At least 4 biopsies from the second part of the duodenum are required 2
Follow-Up Endoscopy Timing
Repeat duodenal biopsy should NOT be routinely performed 1. According to the most recent 2024 guidelines from Nature Reviews Gastroenterology & Hepatology:
- When repeat biopsy is performed, it should generally be done >12 months after diagnosis 1
- The decision should be based on patient characteristics rather than routine protocol 1
Specific Indications for Repeat Gastroscopy
Repeat upper endoscopy is indicated only in these situations 1, 3:
- Persistent or relapsing symptoms without other obvious explanations, even with negative TG2-IgA antibodies 3
- Non-responsiveness to gluten-free diet (lack of clinical improvement)
- Suspicion of refractory coeliac disease (RCeD)
- Suspected complications such as ulcerative jejunitis or enteropathy-associated T-cell lymphoma
- Persistently positive serology (TG2-IgA) suggesting ongoing mucosal damage 3
Critical caveat: Negative serology does NOT guarantee mucosal healing, so symptomatic patients warrant endoscopy regardless of antibody status 3.
Colonoscopy
Colonoscopy is NOT part of routine coeliac disease monitoring 4, 5. It should only be considered in specific clinical scenarios:
Indications for Colonoscopy
Iron deficiency anaemia in patients >45 years old 4
- Diagnostic yield of 12.2% for significant pathology (including 3% colorectal carcinomas) in one study 4
- This is comparable to non-coeliac patients with iron deficiency anaemia
Persistent diarrhoea despite gluten-free diet 4
- Consider flexible sigmoidoscopy initially to exclude microscopic colitis
- Full colonoscopy if sigmoidoscopy is negative or if alarm symptoms present
- Diagnostic yield is lower (2.7%) compared to controls 4
Standard colorectal cancer screening based on age and risk factors (not specific to coeliac disease)
Evidence Limitations
While some studies suggest increased microscopic abnormalities (lymphocytic colitis, melanosis coli) in coeliac patients 5, there is no evidence supporting routine surveillance colonoscopy in asymptomatic coeliac disease patients on a gluten-free diet.
Recommended Monitoring Strategy
Instead of routine endoscopy, the 2024 guidelines recommend 1:
Yearly monitoring should include:
- Dietician assessment of gluten-free diet adherence
- TG2-IgA antibody levels (at 6 months, 12 months, then yearly) 3
- Blood tests: complete blood count, iron status, liver enzymes, vitamins (especially B12, folate, vitamin D)
- Symptom assessment
- Gluten immunogenic peptide testing in urine/stool (emerging tool)
Reserve endoscopy for:
- Enteroscopy with T-cell receptor clonality and flow cytometry when refractory coeliac disease is suspected 1
- Video capsule endoscopy for suspected complications in the small bowel 1
Key Pitfall to Avoid
Do not assume negative antibodies mean mucosal healing. Persistently positive TG2-IgA usually indicates ongoing damage and gluten exposure, but negative serology has limited sensitivity for detecting continued intestinal injury 1, 3. Symptomatic patients require endoscopic evaluation regardless of serology results.